Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 37.29 | N/A |
| PEG Ratio (TTM) | 0.13 | N/A |
| P/S Ratio (TTM) | 1.08 | N/A |
| P/B Ratio (TTM) | 1.65 | N/A |
| P/FCF Ratio (TTM) | 113.35 | N/A |
| Price to 5YR AVG Earnings Ratio | 83.76 | N/A |
| Price to 5YR AVG FCF Ratio | 19.79 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.00% | N/A |
| ROE (TTM) | 4.48% | N/A |
| Net Profit Margin (TTM) | 2.90% | N/A |
| ROIC 5YR AVG | 5.96% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 54.97% | 77.18% | 38.91% |
| Revenue | 1.90% | -6.82% | -4.00% |
| Net Income | 53.31% | 72.07% | 34.05% |
| Cash Flow | 6.00% | -10.74% | -1.82% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.00 | N/A |
| Quick Ratio (TTM) | 1.70 | N/A |
| D/E Ratio (TTM) | 0.59 | N/A |
| Interest Coverage (TTM) | 3.10 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 2.25 | N/A |
| LTL to 5YR AVG FCF | 7.81 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.76% | N/A |